ClinicalTrials.Veeva

Menu

Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus

P

Peking University

Status

Enrolling

Conditions

Autologous Osteoperiosteal Transplantation
Osteochondral Lesion of Talus

Treatments

Procedure: Autologous Osteoperiosteal Transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT06527482
M2023418

Details and patient eligibility

About

The goal of this clinical trial is to establish a multicenter prospective cohort of patients with severe osteochondral lesion of the talus (OLT), evaluate the clinical efficacy of autologous osteoperiosteal transplantation and the incidence of postoperative donor-site morbidity. The main questions it aims to answer are:

Does autologous osteoperiosteal transplantation have good clinical outcomes in the treatment of severe OLT? Does autologous osteoperiosteal transplantation treat severe OLT with fewer postoperative complications?

Participants will:

Undergo autologous osteoperiosteal transplantation for OLT Receive clinical follow-up 3, 6, 12, and 24 months after surgery and answer scales of ankle function assessment Take CT and MRI preoperatively and 12 and 24 months after surgery

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic ankle pain, diagnosed as Osteochondral Lesions of the Talus (OLT);
  • Hepple V OLT on the medial side of the talus or the diameter of the lesion ≥ 8 mm;
  • Conservative treatment of at least 3 months fails to relieve symptoms;
  • Willingness to voluntarily participate in the trial and to sign informed consent.

Exclusion criteria

  • Varus or valgus deformity of the ankle of more than 5 degrees;
  • Grade III injury of the lateral collateral ligament of ankle;
  • Chronic synovitis (rheumatoid arthritis, pigmented villous nodular synovitis, etc.);
  • Joint fibrosis, stiffness, and significantly restricted range of motion;
  • Evidence of moderate to severe knee osteoarthritis on plain radiographs;
  • Failure to complete the rehabilitation protocol as required;
  • Patient medically not fit for surgery, radiographs or MRI;
  • For women, pregnant, planning to be pregnant or lactating.

Trial contacts and locations

1

Loading...

Central trial contact

Qinwei Guo, MD; Qixian Shen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems